|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600121426 |
|
最近更新日期: Date of Last Refreshed on: |
2026-03-31 08:11:53 |
|
注册时间: Date of Registration: |
2026-03-31 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于多模态融合技术的产后抑郁症监测和预警模型研究 |
|
Public title: |
A Study on Monitoring and Early Warning Model for Postpartum Depression Based on Multimodal Fusion Technology |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于多模态融合技术的产后抑郁症监测和预警模型研究 |
|
Scientific title: |
A Study on Monitoring and Early Warning Model for Postpartum Depression Based on Multimodal Fusion Technology |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
罗序楷 |
研究负责人: |
吴琰婷 |
|
Applicant: |
Luo Xukai |
Study leader: |
Wu Yanting |
|
申请注册联系人电话: Applicant telephone: |
+86 178 1984 3575 |
研究负责人电话:
Study leader's |
+86 173 2121 8018 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
17819843575@163.com |
研究负责人电子邮件: Study leader's E-mail: |
yanting_wu@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国上海市杨浦区沈阳路128号 |
研究负责人通讯地址: |
中国上海市杨浦区沈阳路128号 |
|
Applicant address: |
No. 128, Shenyang Road, Yangpu District, Shanghai, China |
Study leader's address: |
No. 128, Shenyang Road, Yangpu District, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
200011 |
研究负责人邮政编码: Study leader's postcode: |
200011 |
|
申请人所在单位: |
复旦大学附属妇产科医院 |
||
|
Applicant's institution: |
The Obstetrics & Gynecology Hospital of Fudan University |
||
|
研究负责人所在单位: |
复旦大学附属妇产科医院 |
||
|
Affiliation of the Leader: |
The Obstetrics & Gynecology Hospital of Fudan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
妇产科伦审2025-176 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
复旦大学附属妇产科医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of The Obstetrics & Gynecology Hospital of Fudan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-09-25 00:00:00 | ||
|
伦理委员会联系人: |
鞠丹丹 |
||
|
Contact Name of the ethic committee: |
Ju Dandan |
||
|
伦理委员会联系地址: |
中国上海市杨浦区沈阳路128号 |
||
|
Contact Address of the ethic committee: |
No. 128, Shenyang Road, Yangpu District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 3318 9900 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
复旦大学附属妇产科医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Obstetrics & Gynecology Hospital of Fudan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国上海市杨浦区沈阳路128号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 128, Shenyang Road, Yangpu District, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市级课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Municipal Project |
||||||||||||||||||||||
|
研究疾病: |
围产期抑郁 |
||||||||||||||||||||||
|
Target disease: |
Perinatal depression |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
开发以人工智能为基础的孕产妇心理健康监测模型,通过对智能手环采集的生命体征数据、临床资料和面部照片等多模态数据的整合分析,构建易行、准确的产后抑郁症预测模型,实现早期预警。 |
||||||||||||||||||||||
|
Objectives of Study: |
Develop an artificial intelligence-based mental health monitoring model for pregnant women. By integrating and analyzing multi-modal data such as vital signs collected by smart wristbands, clinical data, and facial photos, a feasible and accurate prediction model for postpartum depression is constructed to achieve early warning. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
PPD高风险组纳入标准: (1)早孕期(<14周)经EPDS评估可能存在抑郁倾向(分值≥13分); (2)年龄≥18 岁; (3)在复旦大学附属妇产科医院建卡并计划分娩。 PPD低风险组纳入标准: (1)早孕期(<14周)经EPDS评估评估无明显抑郁倾向(分值<12分); (2)年龄≥18 岁; (3)在复旦大学附属妇产科医院建卡并计划分娩。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria for the PPD high-risk group: (1) During the early pregnancy period (less than 14 weeks), there is an assessment of possible depressive tendencies by EPDS (score >= 13 points); (2) Age >=18 years old; (3) Have established a medical record at Fudan University Affiliated Obstetrics and Gynecology Hospital and plan to give birth. Inclusion criteria for the PPD low-risk group: (1) During the early pregnancy period (less than 14 weeks), there is no obvious depressive tendency assessed by EPDS (score < 12 points); (2) Age >= 18 years old; (3) Have established a medical record at Fudan University Affiliated Obstetrics and Gynecology Hospital and plan to give birth. |
||||||||||||||||||||||
|
排除标准: |
排除标准: (1)存在确认的严重健康状况(子痫-重度子痫前期、恶性肿瘤、严重的心脑血管疾病、脑损伤、瘫痪等重大疾患等); (2)孕前和/或妊娠期精神疾病史和/或精神类疾病用药史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria: (1) Presence of confirmed severe health conditions (e.g. eclampsia-severe preeclampsia, malignant tumors, severe cardiovascular or cerebrovascular diseases, brain injury, paralysis, etc.). (2) History of mental disorders before pregnancy and/or during pregnancy, and/or history of medication for mental disorders. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-10-01 00:00:00至 To 2027-10-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-04-01 00:00:00 至 To 2027-10-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
N/A |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表;电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form; Electronic Data Capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |